Table 5.
Cancer rate found in the major meta-analyses about The Bethesda System for Reporting Thyroid Cytology (TBSRTC) and UK Royal College of Pathologists (UK RCPath), and present one about Italian consensus for the classification and reporting of thyroid cytology (ICCRTC)
Classification system | First author of the meta-analysis [ref] | Subcategories of ITN | Cancer rate (95% CI) |
---|---|---|---|
The Bethesda System for Reporting Thyroid Cytology (BSRTC) | Vuong et al. [9] | AUS/FLUS | 31% (24 to 37) |
FN/SFN | 29% (26 to 32) | ||
Straccia et al. [10] | AUS/FLUS | 27% (23 to 31) | |
FN/SFN | 31% (28 to 36) | ||
UK Royal College of Pathologists (UK RCPath) | Poller et al. [8] | Thy3a | 25% (20 to 31) |
Thy3f | 31% (24 to 39) | ||
Italian consensus for the classification and reporting of thyroid cytology (ICCRTC) | Trimboli [present] | TIR3A | 12% (9 to 16) |
TIR3B | 44% (40 to 49) |
All numbers are rounded to the nearest decimal
ITN indeterminate thyroid nodule at FNAC, 95% CI 95% confidence interval